Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MRP
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Matthew B. Gorson Director | MRP Millrose Properties, Inc. | Buy | 3,000 | $28.80 | $86.4K Buy | Form 4 ↗ |
| Aug 7, 2026 | Carlos A. Migoya Director | MRP Millrose Properties, Inc. | Buy | 1,000 | $29.18 | $29.2K Buy | Form 4 ↗ |
| May 18, 2026 | Matthew B. Gorson Director | MRP Millrose Properties, Inc. | Buy | 4,500 | $26.97 | $121.4K Buy | Form 4 ↗ |
| May 13, 2026 | Rachel Presa General Counsel and Secretary | MRP Millrose Properties, Inc. | Buy | 307 | $26.62 | $8,172 Buy | Form 4 ↗ |
| May 12, 2026 | Robert Nitkin Chief Operating Officer | MRP Millrose Properties, Inc. | Buy | 1,840 | $26.60 | $48.9K Buy | Form 4 ↗ |
| May 11, 2026 | Rachel Presa General Counsel and Secretary | MRP Millrose Properties, Inc. | Buy | 725 | $27.18 | $19.7K Buy | Form 4 ↗ |
| May 11, 2026 | Darren Richman See Remarks | MRP Millrose Properties, Inc. | Buy | 40,000 | $27.31 | $1.1M Buy | Form 4 ↗ |
| May 11, 2026 | Darren Richman See Remarks | MRP Millrose Properties, Inc. | Buy | 195,000 | $27.31 | $5.3M Buy | Form 4 ↗ |
| Mar 5, 2026 | Matthew B. Gorson Director | MRP Millrose Properties, Inc. | Buy | 1,000 | $30.67 | $30.7K Buy | Form 4 ↗ |
| Nov 26, 2025 | Carlos A. Migoya Director | MRP Millrose Properties, Inc. | Buy | 219 | — | — Buy | Form 4 ↗ |
| Nov 24, 2025 | Kathleen B. Lynch Director | MRP Millrose Properties, Inc. | Buy | 1,860 | $31.74 | $59.0K Buy | Form 4 ↗ |
| Nov 12, 2025 | Carlos A. Migoya Director | MRP Millrose Properties, Inc. | Buy | 1,000 | $32.24 | $32.2K Buy | Form 4 ↗ |
| Oct 30, 2025 | Rachel Presa General Counsel and Secretary | MRP Millrose Properties, Inc. | Buy | 242 | $32.37 | $7,834 Buy | Form 4 ↗ |
| Oct 30, 2025 | Rachel Presa General Counsel and Secretary | MRP Millrose Properties, Inc. | Buy | 234 | $32.33 | $7,565 Buy | Form 4 ↗ |
| Oct 29, 2025 | Matthew B. Gorson Director | MRP Millrose Properties, Inc. | Buy | 2,500 | $32.69 | $81.7K Buy | Form 4 ↗ |
| Oct 28, 2025 | Patrick J. Bartels Jr. Director | MRP Millrose Properties, Inc. | Buy | 7,500 | $32.52 | $243.9K Buy | Form 4 ↗ |
| May 21, 2025 | Adil Pasha Chief Technology Officer | MRP Millrose Properties, Inc. | Buy | 2,500 | $28.34 | $70.8K Buy | Form 4 ↗ |
| May 20, 2025 | Patrick J. Bartels Jr. Director | MRP Millrose Properties, Inc. | Buy | 8,750 | $28.62 | $250.4K Buy | Form 4 ↗ |
| May 19, 2025 | Patrick J. Bartels Jr. Director | MRP Millrose Properties, Inc. | Buy | 8,750 | $28.36 | $248.2K Buy | Form 4 ↗ |
| May 19, 2025 | Matthew B. Gorson Director | MRP Millrose Properties, Inc. | Buy | 7,500 | $28.24 | $211.8K Buy | Form 4 ↗ |
| Mar 5, 2025 | Carlos A. Migoya Director | MRP Millrose Properties, Inc. | Buy | 3,458 | $22.45 | $77.6K Buy | Form 4 ↗ |
| Mar 3, 2025 | Carlos A. Migoya Director | MRP Millrose Properties, Inc. | Buy | 3,259 | $22.89 | $74.6K Buy | Form 4 ↗ |
| Mar 3, 2025 | Rachel Presa General Counsel and Secretary | MRP Millrose Properties, Inc. | Buy | 354 | $22.83 | $8,082 Buy | Form 4 ↗ |
| Mar 3, 2025 | Rachel Presa General Counsel and Secretary | MRP Millrose Properties, Inc. | Buy | 638 | $22.79 | $14.5K Buy | Form 4 ↗ |
| Mar 3, 2025 | Garett Rosenblum See Remarks | MRP Millrose Properties, Inc. | Buy | 5,900 | $22.84 | $134.8K Buy | Form 4 ↗ |
| Feb 20, 2025 | Robert Nitkin Chief Operating Officer | MRP Millrose Properties, Inc. | Buy | 3,225 | $23.55 | $75.9K Buy | Form 4 ↗ |
| Feb 14, 2025 | Darren Richman See Remarks | MRP Millrose Properties, Inc. | Buy | 44,000 | $23.00 | $1.0M Buy | Form 4 ↗ |
| Feb 13, 2025 | Matthew B. Gorson Director | MRP Millrose Properties, Inc. | Buy | 2,500 | $22.59 | $56.5K Buy | Form 4 ↗ |
| Feb 13, 2025 | Carlos A. Migoya Director | MRP Millrose Properties, Inc. | Buy | 3,389 | $22.00 | $74.6K Buy | Form 4 ↗ |
| Feb 13, 2025 | Darren Richman See Remarks | MRP Millrose Properties, Inc. | Buy | 176,152 | $22.70 | $4.0M Buy | Form 4 ↗ |
| Feb 13, 2025 | Darren Richman See Remarks | MRP Millrose Properties, Inc. | Buy | 44,848 | $22.09 | $990.7K Buy | Form 4 ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:02 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances